IntrinsicIntrinsic
← Scroll for more →

Financial Statements — IPEXU

Balance Sheet

(in millions USD)
MetricQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024
Cash & Equivalents0.060.010.030.290.500.500.00
Total Current Assets0.160.190.190.350.560.59--
Total Non-current Assets*90.9290.1289.3488.4987.5786.67--
Total Assets91.0890.3189.5388.8488.1387.260.13
Accounts Payable2.922.612.270.660.020.020.00
Total Current Liabilities2.922.612.270.660.020.02--
Total Non-current Liabilities4.254.153.953.953.953.95--
Total Liabilities7.176.766.224.613.973.970.11
Retained Earnings(7.02)(6.58)(6.03)(4.26)(3.42)(3.38)(0.01)
Total Stockholder Equity(7.01)(6.57)(6.03)(4.26)(3.42)(3.38)0.02
← Scroll for more columns →

* Derived from reported values

Income Statement

(in millions USD)
MetricQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025
Operating Income(0.44)(0.55)(1.77)(0.86)(0.05)(0.04)
Net Income0.360.24(0.92)0.070.860.38
← Scroll for more columns →

Cash Flow Statement

(in millions USD)
MetricQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025
Operating Cash Flow(0.05)(0.21)(0.26)(0.21)(0.01)(0.22)
Investing Cash Flow----0.000.000.00(86.25)
Financing Cash Flow0.100.20-0.000.000.0086.97
← Scroll for more columns →